Past CureTalks
Unraveling the Complexities of BRCA-Related Breast and Ovarian Cancers
The BRCA1 (BReast CAncer gene 1) and BRCA2 are genes that produce proteins crucial for DNA repair. Since these proteins play a pivotal role in cellular resilience against DNA damage — mutations leading to inactivation of these genes results in…
The Nuances of Egg Freezing – All You Should Know
The egg freezing procedure has not only given hope to those women who want to preserve their fertility due to medical issues, but also to those who just want to extend their fertility. Just 475 women froze their eggs in…
Bridging the Gap in Multiple Myeloma Survival
What is the gap in myeloma survival? Currently the National Cancer Institute reports a life expectancy of just over five years, whereas, myeloma specialists at myeloma centers of excellence have reported a life expectancy of over ten years for myeloma…
What’s New in Multiple Myeloma Management?
Multiple myeloma is diagnosed in over 100,000 patients each year worldwide. The FDA recently granted accelerated approval to Teclistamab, the first bispecific B-cell maturation (BCMA)-directed CD3 T-cell engager. The therapeutic armamentarium for myeloma now includes alkylating agents, corticosteroids, deacetylase inhibitors,…